A detailed history of Titleist Asset Management, Ltd. transactions in Abbott Laboratories stock. As of the latest transaction made, Titleist Asset Management, Ltd. holds 3,199 shares of ABT stock, worth $362,414. This represents 0.08% of its overall portfolio holdings.

Number of Shares
3,199
Previous 3,438 6.95%
Holding current value
$362,414
Previous $333,000 5.41%
% of portfolio
0.08%
Previous 0.08%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Jan 12, 2023

SELL
$95.06 - $111.52 $22,719 - $26,653
-239 Reduced 6.95%
3,199 $0
Q3 2022

Nov 14, 2022

SELL
$96.76 - $112.03 $12,288 - $14,227
-127 Reduced 3.56%
3,438 $333,000
Q2 2022

Aug 15, 2022

SELL
$102.07 - $123.37 $129,220 - $156,186
-1,266 Reduced 26.21%
3,565 $387,000
Q1 2022

May 04, 2022

BUY
$114.02 - $139.04 $4,332 - $5,283
38 Added 0.79%
4,831 $572,000
Q4 2021

Feb 17, 2022

BUY
$115.53 - $141.46 $553,735 - $678,017
4,793 New
4,793 $675,000

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $198B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Titleist Asset Management, Ltd. Portfolio

Follow Titleist Asset Management, Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Titleist Asset Management, Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Titleist Asset Management, Ltd. with notifications on news.